Atlas FDA

GQX

11 FDA 510(k) clearances · Product code

126 daysmedian time to decision
239 days90th percentile
11clearances measured

FDA profile

Official device name
Antiserum, Cf, Varicella-Zoster
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3900
Medical specialty
Microbiology
Flags
Third-party review eligible
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
VARICELLA-ZOSTER VIRUS DIRECT IMMUNOFLUORESCENCE ASSAY (K951799)Light Diagnostics1996-03-20
VZV IGM TEST (K911301)Gull Laboratories, Inc.1991-07-17
VIRGO(R) VZV-IGG ELISA (K883427)Electro-Nucleonics, Inc.1989-03-10
VZV TEST (K875358)Gull Laboratories, Inc.1988-03-31
ENZYGNOST ANTI-VZV IGG TEST (K863317)Behring Diagnostics, Inc.1987-04-22
FIAX TEST KIT FOR VARICELLA ANTIBODY SEROLOGY (K853540)Idt, A Division of Whittaker M.A. Bioproducts1986-02-04
VARICELLA-ZOSTER-COMPLE FIX ANTIGEN AND NEG CONTRO (K852930)Microbix Biosystems, Inc.1985-11-12
GLB VARICELLA-ZOSTER VIRUS FLUORESCENT (K842096)Great Lakes Bioscience1985-01-07
ORTHO VARICELLA-ZOSTER VIRUS IDENT. (K841526)Ortho Diagnostic Systems, Inc.1984-06-25
VARICELLA-ZOSTER FA LABELLED (8-321 RF) (K770806)Flow Laboratories, Inc.1977-05-20
VARICELLA-ZOSTER FA LABELED PRESERUM (K770810)Flow Laboratories, Inc.1977-05-20

Track GQX automatically

Every clearance here is in the API, with alerts when new ones post.